The University of Manchester Pharmacology PhD Projects, Programmes & Scholarships

We have 7 The University of Manchester Pharmacology PhD Projects, Programmes & Scholarships

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

The University of Manchester Faculty of Biology, Medicine and Health

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more

Supervisors: Prof D Brough, Dr K Couper

13 May 2024 PhD Research Project Competition Funded PhD Project (UK Students Only)

More Details

Inflammatory Arthritis in Childhood: Impact, Outcomes and Safety of Treatment

The University of Manchester Faculty of Biology, Medicine and Health

Juvenile Idiopathic Arthritis is the most common inflammatory arthritis of childhood. Although less common than arthritis in adults, a diagnosis of arthritis in a child can have lasting impacts on that child and their families through their entire lifespan. Read more

Supervisors: Prof K Hyrich, Dr L Kearsley-Fleet

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

PBPK modelling of disease-drug interactions using transporter and enzyme biomarker data

The University of Manchester Faculty of Biology, Medicine and Health

Precision dosing strategies require accounting for between-patient variability in pharmacokinetics. Read more

Supervisors: Dr A Galetin, Dr Daniel Scotcher, Prof A Rostami

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

The epigenomic, transcriptional and diagnostic architecture of neurodevelopmental disorders caused by exposure to maternal infection

The University of Manchester Faculty of Biology, Medicine and Health

A fundamental unknown in understanding mechanisms of disease, and therefore improving therapy, is how stressors experienced during critical developmental periods influence the genesis or ‘programming’ of adult disease (Estes & McAllister 2016). Read more

Supervisors: Dr R Hager, Dr M Harte, Dr J Glazier

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Drug repurposing for the treatment of aspergillosis

The University of Manchester Faculty of Biology, Medicine and Health

The mould Aspergillus fumigatus was classified by the WHO as a critical priority pathogen in 2022. It causes a spectrum of invasive, allergic and chronic disease. Read more

Supervisors: Dr CK Kosmidis, Prof D Ashcroft, Dr M Bottery, Dr M Bromley

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Inducing ferroptotic death to kill cancer cells

The University of Manchester Faculty of Biology, Medicine and Health

Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more

Supervisors: Dr C Tournier, Dr K Finegan

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Adverse Events to Methotrexate in Inflammatory Arthritis: Does Age Matter?

The University of Manchester Faculty of Biology, Medicine and Health

A consistent top-5 research priority for both children and adults with inflammatory arthritis is the tailoring of treatments to prevent or lessen adverse events. Read more

Supervisors: Dr S Shoop-Worrall, Prof K Hyrich, Dr S Verstappen

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

We have 7 The University of Manchester Pharmacology PhD Projects, Programmes & Scholarships

The University of Manchester Pharmacology PhD Projects, Programmes & Scholarships

We have 7 The University of Manchester Pharmacology PhD Projects, Programmes & Scholarships

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

Inflammatory Arthritis in Childhood: Impact, Outcomes and Safety of Treatment

PBPK modelling of disease-drug interactions using transporter and enzyme biomarker data

The epigenomic, transcriptional and diagnostic architecture of neurodevelopmental disorders caused by exposure to maternal infection

Drug repurposing for the treatment of aspergillosis

Inducing ferroptotic death to kill cancer cells

Adverse Events to Methotrexate in Inflammatory Arthritis: Does Age Matter?

Select your nearest city

Do you want hassle-free information and advice?